瘤微环境中的免疫调节机制以及针对性治疗的含义
Paulina Czajka-Francuz1, Maria J Prendes2, Arun Mankan1
1Fortrea, Inc., Durham, NC, United States.
Frontiers in oncology
|July 10, 2023
概括
癌症疗法面临着免疫抑制瘤微环境 (TME) 的挑战. 了解免疫逃生机制推动了新的疗法,如表观遗传治疗,以重新编程TME以获得抗瘤效果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 瘤微环境 (TME) 显著限制了癌症治疗的有效性.
- 在TME中的免疫抑制涉及细胞,幽默,代谢,遗传和表观遗传因素的复杂相互作用.
- 识别免疫逃生机制对于开发有效的癌症治疗至关重要.
研究的目的:
- 提供TME中关键免疫抑制机制的概述.
- 讨论这些机制对向癌症疗法的影响.
- 要突出最近在为抗瘤反应重新编程TME方面取得的进展.
主要方法:
- 关于瘤微环境免疫抑制的当前文献的综述.
- 对已识别的免疫逃生机制的分析.
- 讨论针对TME的治疗策略.
主要成果:
- 发现了许多免疫逃生机制,涉及TME的各种细胞和非细胞组成部分.
- 开发新型疗法,包括小分子,纳米药物,免疫检查点抑制剂,采用细胞疗法和表观遗传疗法.
- 这些疗法显示出重编程TME并增强抗瘤免疫力的潜力.
结论:
- 针对TME中的免疫抑制机制是改善癌症治疗结果的有希望的策略.
- 重编程TME可以将宿主免疫反应转向抗瘤效应.
- 了解和准TME的进步导致了临床癌症治疗的重大突破.
更多相关视频
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Cytotoxic T Cells-mediated Immune Response
985
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
985
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cell-mediated Immune Responses
69.0K
Overview
69.0K
T Cell Activation and Clonal Selection
822
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
822


